0000950170-24-066215.txt : 20240529
0000950170-24-066215.hdr.sgml : 20240529
20240529211200
ACCESSION NUMBER: 0000950170-24-066215
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240523
FILED AS OF DATE: 20240529
DATE AS OF CHANGE: 20240529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seelenberger Alexander A.
CENTRAL INDEX KEY: 0001832562
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39244
FILM NUMBER: 241000504
MAIL ADDRESS:
STREET 1: 4500 GREAT AMERICA PKWY
STREET 2: STE. 100 #29
CITY: SANTA CLARA
STATE: CA
ZIP: 95054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vincerx Pharma, Inc.
CENTRAL INDEX KEY: 0001796129
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 833197402
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 260 SHERIDAN AVENUE
STREET 2: SUITE 400
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-800-6676
MAIL ADDRESS:
STREET 1: 260 SHERIDAN AVENUE
STREET 2: SUITE 400
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Vincera Pharma, Inc.
DATE OF NAME CHANGE: 20201223
FORMER COMPANY:
FORMER CONFORMED NAME: LifeSci Acquisition Corp.
DATE OF NAME CHANGE: 20191206
4
1
ownership.xml
4
X0508
4
2024-05-23
0001796129
Vincerx Pharma, Inc.
VINC
0001832562
Seelenberger Alexander A.
260 SHERIDAN AVENUE, SUITE 400
PALO ALTO
CA
94306
false
true
false
false
Chief Financial Officer
false
Stock Option (right to buy)
7.38
2024-05-23
4
A
false
31250
0.00
A
2034-03-06
Common Stock
31250
125000
D
The option grant was approved on March 7, 2024, subject to stockholder approval of an amendment to the Vincerx Pharma, Inc. 2020 Stock Incentive Plan. The stockholders approved the amendment on May 23, 2024.
One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter.
By: /s/ Dr. Ahmed M. Hamdy, attorney-in-fact
2024-05-29